Another new basal insulin, degludec, is available in Japan

Japan has approved use of a new basal insulin from Novo Nordisk, insulin degludec.  It is being promoted by the company as having a duration of action up to 42 hours.  The press release is here.

#Diabetesmellitus #insulin #japan #novonordisk